Krystal Biotech Inc (KRYS NASDAQ) stock market data APIs
$274.5966
-1.17(-0.4%)
as of February 13, 2026
Try our APIs with
free plan!
Krystal Biotech Inc Financial Data Overview
Price chart is built with
Anychart
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Prev. Close
274.5966
Open
273.4238
High
283.0093
Low
272.7462
52 wk Range
122.8-295.98
Market Cap
8 016 M
P/E Ratio
41.509
Shares Outstanding
28 998 K
Revenue
373 M
EPS
2.66
Beta
0.478
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Krystal Biotech Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Krystal Biotech Inc data using free add-ons & libraries
Get Krystal Biotech Inc Fundamental Data
Krystal Biotech Inc Fundamental data includes:
- Net Revenue: 373 M
- EBITDA: 160 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 1.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Krystal Biotech Inc News
New
Krystal Biotech, Inc. Q4 2025 Earnings Call Summary
Krystal Biotech, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Global Commercial Scaling Management attributed Q4 performance to successful US sales force expansion and initial r...
Krystal Biotech Q4 Earnings Call Highlights
Krystal Biotech logo Key Points VYJUVEK net revenue was $107.1M in Q4 and $389.1M for 2025 (≈34% YoY), lifetime VYJUVEK sales exceed $730M, gross margins were ~94% and the company finished 2025 wi...
Assessing Krystal Biotech (KRYS) Valuation After RMAT Designation For KB707 Immunotherapy Candidate
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. RMAT designation for KB707 puts Krystal Biotech in focus Krystal Biotech (KRYS...
RMAT Puts Krystal Biotech’s KB707 At Center Of Oncology Story
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Krystal Biotech (NasdaqGS:K...
Get Krystal Biotech Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
